Retrovirus Like Particles (RVLP) are endogenously produced by common cell lines (ex. CHO, NS0) used during the production of biopharmaceuticals.
Retroviral clearance validation is an international regulatory requirement.
Coming soon: The RVLP-Kit contains an RVLP stock solution derived from CHO and reagents for QPCR analysis
Under Development
